Chronic hepatitis B and C explained: when treatment starts, how the antivirals differ, monitoring, and long-term outlook.
Both are sofosbuvir-based hepatitis C treatments, but they pair it with different partner drugs and cover different genotypes. The factual differences, and who decides.
Hepatitis C is priced by the course, not the month. What a full course costs across the main direct-acting antiviral regimens, and how generics changed the figure.
Chronic hepatitis B explained: the four tests that decide whether you need medication, how entecavir, TDF and TAF differ, what suppression does and does not achieve, and why treatment usually continues indefinitely.
